Oral & Injectable Medications Flashcards
7 cards from real Diabetes practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Oral & Injectable Medications flashcards as text
Which SGLT-2 inhibitor has FDA approval specifically for reducing the risk of hospitalization for heart failure in patients with type 2 diabetes?
Answer: Dapagliflozin (Farxiga)
Dapagliflozin (Farxiga) is FDA-approved to reduce the risk of hospitalization for heart failure in type 2 diabetes based on the DECLARE-TIMI 58 trial.
A patient rotates insulin injection sites incorrectly and always injects in the same spot. What complication may develop?
Answer: Lipohypertrophy
Repeated injections at the same site cause lipohypertrophy — a buildup of fatty tissue that impairs insulin absorption.
For patients requiring insulin who have significant insulin resistance and large total daily doses, which concentrated insulin formulation may be appropriate?
Answer: Insulin glargine U-300 (Toujeo)
Insulin glargine U-300 (Toujeo) delivers three times the units per mL, reducing injection volume for highly insulin-resistant patients.
Which oral diabetes agent has demonstrated both cardiovascular mortality benefit AND renal protective effects, making it a preferred agent in T2DM with CKD?
Answer: Empagliflozin
Empagliflozin (Jardiance) showed cardiovascular mortality reduction in EMPA-REG OUTCOME and renal protection in EMPEROR-Reduced/Preserved trials.
A diabetes educator notes a patient's insulin pen needle is not changed after every injection. What patient education point is most important?
Answer: Reusing needles causes blunting and barbing, leading to painful injections and inconsistent delivery
Pen needles are single-use; reuse causes microscopic barbs and tip distortion, resulting in pain, lipohypertrophy, and unpredictable insulin absorption.
Glucagon emergency kits are prescribed for patients with type 1 diabetes on insulin. What is the standard adult IM dose?
Answer: 1 mg
The standard adult dose of glucagon for severe hypoglycemia is 1 mg administered intramuscularly, subcutaneously, or intranasally.
Which class of diabetes medication is associated with an increased risk of urinary tract infections and lower limb amputations as noted in FDA labeling?
Answer: SGLT-2 inhibitors
SGLT-2 inhibitors, particularly canagliflozin, carry FDA warnings for increased risk of lower limb amputation and urinary tract infections.